Education
About Us
Working with TipRanks
Follow Us
Claritas Pharmaceuticals (CLAZF)
OTHER OTC:CLAZF
| Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -3.28M | $ -9.45M | $ -11.10M | $ -14.50M |
| EBITDA | $ -2.79M | $ -16.72M | $ 18.14M | $ -15.44M |
| Net Income | $ 4.21M | $ -21.21M | $ 6.93M | $ -31.86M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 5.00K | $ 32.00K | $ 227.00K | $ 3.69M |
| Total Assets | $ 10.45M | $ 25.25M | $ 59.61M | $ 65.28M |
| Total Debt | $ 925.00K | $ 736.00K | $ 246.00K | $ 2.87M |
| Net Debt | $ 920.00K | $ 704.00K | $ 19.00K | $ -818.00K |
| Total Liabilities | $ 8.94M | $ 28.69M | $ 49.85M | $ 76.91M |
| Stockholders' Equity | $ 1.51M | $ -3.44M | $ 9.76M | $ -11.63M |
| Cash Flow | ||||
| Free Cash Flow | $ -309.00K | $ -6.48M | $ -4.85M | $ -5.56M |
| Operating Cash Flow | $ -309.00K | $ -6.48M | $ -4.85M | $ -5.56M |
| Investing Cash Flow | $ 2.11K | $ -188.00K | $ 0.00 | $ -10.00M |
| Financing Cash Flow | $ 294.79K | $ 6.48M | $ 1.39M | $ 18.57M |
Claritas Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.